(800)525-7111 Free Consultation

Potential Zantac Lawsuit Payout: What Can Victims Expect?

Many potential plaintiffs may be wondering, “What kind of Zantac lawsuit payout may be on the horizon?”

It is estimated that over 15 million Americans have taken prescription ranitidine, know popularly under the brand name Zantac, which the FDA has identified as a probable carcinogen. Millions may be at risk of developing cancer due to NDMA-contaminated Zantac and generic ranitidine.

To be clear, there are never any guarantees and every case is different. The specific outcome of any Zantac claim or litigation will depend on the unique facts and circumstances of that case.

***Disclaimer: No settlement agreement has been reached in any litigation regarding ranitidine (ZANTAC®), including in the Multidistrict Litigation in the United States District Court for the Southern District of Florida (case no. 20-MD-2924). 

Zantac Lawsuit Payouts - What Can Victims Expect - Riddle & BrantleyThat said, legal analysts anticipate that Zantac cancer lawsuits may result in significant settlements or verdicts against large manufacturers, potentially resulting in millions of dollars in total compensation paid to victims.

IMPORTANT: If you or a loved one have developed cancer after taking brand-name Zantac, you may qualify for a Zantac class action lawsuit. Victims deserve justice.

Call 1-800-525-7111 today or fill out our convenient form for a FREE consultation with one of Riddle & Brantley’s experienced Zantac lawyers who will review your case to see if you qualify for compensation.

IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents.

What Kind of a Potential Payout Can Zantac Victims Expect?

With any dangerous drug lawsuit, any potential Zantac lawsuit settlement payout amount that each victim receives (which is not guaranteed and there have been no settlements in any Zantac litigation so far) is based on a variety of factors, including:

  • Evidence supporting each plaintiff’s claims
  • Number of plaintiffs involved
  • Final settlement amount
  • Severity of each plaintiff’s damages

“What Can I Recover from a Zantac Lawsuit?”

It is impossible to estimate what type of Zantac lawsuit payout may be available to victims. However, many similar dangerous drug lawsuits have reached settlements that may foreshadow Zantac lawsuit payouts (see “Recent Dangerous Drug Lawsuit Results” section below). Keep in mind that there are no guarantees that any Zantac lawsuit will result in a settlement. To date, Zantac manufacturers like GlaxoSmithKline (GSK) and Sanofi have not agreed to any settlements and strongly deny any alleged negligence or wrongdoing.

What Will a Global Settlement in Zantac Lawsuits Look Like?

Zantac lawsuits have been consolidated into multidistrict litigation (MDL) in the Southern District of Florida. In an MDL, attorneys representing both plaintiffs and defendant(s) may agree to a “global settlement” that covers multiple claims (sometimes hundreds or thousands of them). However, any potential Zantac global settlement would result in different compensation for individual plaintiffs in the MDL. This is because in mass tort cases like Zantac lawsuits, claims are consolidated to streamline the legal process but each plaintiff’s case remains separate with its own facts, circumstances, and supporting evidence. Global settlements often categorize claims in “tiers” based on the severity of injuries, and individual payouts further depend on the evidence supporting each claim.

Global settlements are often influenced by the outcome of early “bellwether” trials. Bellweather trials are used by plaintiffs and defense attorneys to gauge the strength of evidence for and against the claims, and juries’ early verdicts often impact the defense’s willingness to engage in settlement negotiations. The first of Zantac bellwether trials is currently scheduled to begin on October 22, 2022 and legal analysts will be closely tracking this case for clues as to how Zantac litigation may resolve.

Remember, as of late 2021, no global settlement has been agreed to in the Zantac litigation. Defendants strongly deny any alleged negligence and/or wrongdoing.

Caveats to Settlement Projections

There is no way to accurately predict potential Zantac settlement amounts with 100% confidence. To be clear, no settlements have been agreed to as of late 2021, and defendants strongly deny liability. Remember, the results of any case depend on the unique facts and circumstances of the case. Riddle & Brantley’s Zantac lawsuit attorneys are closely tracking the progression of Zantac litigation and we remain committed to seeking maximum compensation for our deserving clients.

Recent Dangerous Drug Lawsuit Results

Other lawsuits involving dangerous drugs may offer clues as to what any potential Zantac settlement payouts may look like. We cannot predict any potential settlement amounts with 100% confidence. Legal analysts do anticipate, however, that as with the case results listed below, any potential Zantac settlement may be significant.

Risperdal (2013—)

In 2013, manufacturer Johnson & Johnson agreed to two settlements totaling $181 million and $2.2 billion, respectively, to resolve allegations that the company promoted the prescription drug Risperdal for off-label uses. In 2019, the company was also hit with an $8 billion verdict in a lawsuit alleging that it attempted to hide dangerous side effects of the medication.

Actos (2015)

In April 2015, pharmaceutical manufacturer Takeda agreed to pay out $2.5 billion to settle thousands of lawsuits brought against it that claimed its diabetes medication Actos was linked to an increased risk of bladder cancer. In one case, a judge in Louisiana ordered that Takeda pay $9 billion in punitive damages due to the court’s determination that “Takeda had hidden the cancer risks.”

Yasmin (2019)

Since 2012, Bayer has been inundated with lawsuits that claim the company downplayed the risk of blood clots and stroke associated with its popular birth control drug Yasmin, potentially resulting in thousands of serious injuries. As of 2019, it was reported that Bayer had set aside over $262.5 million to settle lawsuits associated with Yasmin.

Every Claim is Unique and Results Are Not Guaranteed

Potential Zantac Payouts - Riddle & BrantleyIn any of these cases, the settlement each claimant receives varies depending on a variety of factors, including the severity of their injuries and evidence supporting their claims. In any dangerous drug lawsuit, compensation is never guaranteed.

However, if you’ve potentially suffered cancer due to brand-name Zantac, our experienced team at Riddle & Brantley can fight to protect your right to justice.

If you or a loved one has taken brand-name Zantac and has later suffered from cancer, call us today at 1-800-525-7111 for a FREE, no-obligation consultation.

You may be entitled to a potential Zantac lawsuit payout in the form of financial compensation and you deserve justice.

“Do I Qualify for a Zantac Lawsuit?”

You may qualify for a Zantac lawsuit if you meet the following criteria:

  • Used brand-name Zantac only
  • Suffered from at least one of the following cancers:
    • Bladder cancer
    • Liver cancer
    • Stomach cancer
    • Esophageal cancer
    • Pancreatic cancer
    • Lung cancer
    • Colorectal cancer
    • Prostate cancer
  • Must have used brand-name Zantac after October 1984
  • Must have used brand-name Zantac for a minimum of one year
  • Must have used brand-name Zantac once per week for a minimum of six months
  • Must have been diagnosed with a qualifying cancer within 20 years of last dose
  • Must not have been a smoker in the past 20 years if diagnosed with lung cancer
  • Must be 64 years of age or younger at the time of diagnosis if diagnosed with prostate cancer

Certain other criteria may apply. For a FREE, no-obligation consultation with an experienced Zantac lawsuit attorney, please call 1-800-525-7111.

“It was nice to see Riddle & Brantley put me and my needs first.”

R. Colley, Riddle & Brantley client

IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents.

“I Believe I Qualify for a Zantac Lawsuit, What Should I Do Next?”

Experienced Zantac Cancer Lawsuit Attorneys - Riddle & BrantleyPharmaceutical companies routinely retain high-dollar legal teams so that they can deny responsibility for injuries and suffering potentially caused by possibly dangerous drugs and defective medical devices. 

You deserve an experienced team on your side experienced in fighting for the rights of their clients against potentially negligent manufacturers. We are committed to seeking maximum compensation in potential Zantac settlement payouts or verdicts, however there are no guarantees and no settlements have been agreed to as of late 2021.

At Riddle & Brantley, our attorneys have over 220+ years of combined experience fighting against dangerous drug manufacturers, and have recovered more than $600 million for our clients in the last 20 years alone (see disclaimer below).

You’ve been through enough. You deserve a legal team that fights for your rights, so you can focus on healing and improving your quality of life.

“This settlement changed me and my family’s lives.”

Linda B., Riddle & Brantley client

At Riddle & Brantley, you won’t pay any attorney fees unless we win compensation for you. 

Call us today at 1-800-525-7111 or fill out our convenient form below to speak with one of our experienced Zantac lawyers and find out if you may be entitled to compensation.

At Riddle & Brantley, we are dedicated to showing each and every one of our clients that Justice Counts.

 


***Disclaimer: No settlement agreement has been reached in any litigation regarding ranitidine (ZANTAC®), including in the Multidistrict Litigation in the United States District Court for the Southern District of Florida (case no. 20-MD-2924). 

*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.